BCL2 and acute myeloid leukemia: Based on the evidence of TRAIL-mediated CASP 8-dependent extrinsic apoptosis in AML cells with highTP53INP2 expression, we evaluated whether the addition of the BCL-2 inhibitor venetoclax (VEN) enhanced TRAIL sensitivity in AML cells in vitro.